As per annexure enclosed

Pat Growth 25pctEbitda Margin ExpansionExceptional ItemRelated Party TransactionsResults View source PDF

APOLLOHOSP · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close

+3.4%1-day move

₹8075.00

prior close

₹8198.50

base price

After-mkt

timing

5m10m15m30m1D2D3D4D5D7D15D1M2M3M

-1.7-0.7-0.2+1.9+3.4+4.2+2.4+2.5+1.8+0.6+5.3+4.9+10.4—

Up moveDown movePending

AI summary

Apollo Hospitals reported strong FY2025-26 results. Standalone revenue grew 13.7% to Rs.93,262 million with PAT up 15.1% to Rs.14,926 million and EPS at Rs.103.81. Consolidated revenue rose 15.7% to Rs.252,285 million with PAT jumping 33% to Rs.20,027 million and EPS at Rs.135.04. The Board recommended a final dividend of Rs.10 per share (total dividend Rs.20 including interim). Key corporate actions include merger of Apollo Hospitals North Limited (wholly owned subsidiary), divestment of Apollo Specialty Hospitals and Apollo Fertility to Cloudnine for Rs.15,500 million, and re-appointment of Executive Chairman Dr. Prathap Reddy and Independent Director Ms. Rama Bijapurkar. Statutory auditors issued unmodified opinions. Credit ratings remain AAA/AA+.

Likely market impact

Strong operational performance with 33% PAT growth on consolidated basis and positive corporate restructuring moves should support the stock. The Cloudnine transaction and subsidiary mergers indicate strategic portfolio optimization.